Gene Therapy in Treating Patients With Cancer

Completed · Phase 1

Conditions studied: Cancer

In brief

RATIONALE: Inserting a gene that has been created in the laboratory into a person's white blood cells may make the body build an immune response to kill cancer cells. PURPOSE: Phase I trial to study the effectiveness of gene therapy in treating patients who have cancer that has not responded to previous therapy.

Key facts

Study ID

NCT00004178

Run by

Roger Williams Medical Center

Starts

1998-04-01

Expected to finish

2001-12-01

Last updated by the study team

2011-06-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.